Process for the enzymatic racemate cleavage of racemic alcohols with/in vinyl esters by transesterification.
6 claims: 3 independent, 3 dependent
- 1Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen, dadurch gekennzeichnet, daß man einen Vinylester der Formel I, in der R 1 Wasserstoff, C 1 -C 18 -Alkyl, welches gegebenenfalls mit Halogen substituiert ist, Phenyl oder C 1 -C 3 -Alkoxy-Ci -C 4 -Alkyl und R 2 Wasserstoff oder Methyl bedeutet, in Gegenwart von Lipasen aus Schweineleber, Schweinepankreas sowie aus Mikroorganismen, wie Candida, Mucor, Rhizopus, Penicillium, Aspergillus und Pseudomonas umsetzt mit einem Alkohol der Formel II in der R 3 C i -C 18 -Alkyl, C3-Clo-Cycloalkyl bedeutet, wobei diese Reste auch halogensubstituiert sein können, und R 4 Epoxi-C 1 -C 5 -Alkyl bedeutet, wobei die Epoxi-Gruppe in β-Position zur OH-Gruppe im Rest der Formel II steht oder R 4 C 1 -C 10 -Alkyl, C 2 -C 10 -Alkenyl, C 2 -C 10 -Alkinyl, C 3 -C 8 -Cycloalkenyl bedeutet, wobei die Alkyl-, Alkenyl-, Alkinyl- und Cycloalkenylreste gegebenenfalls mit COOH, Halogen, N0 2 , CN, C 1 -C 4 -Alkoxycarbonyl oder Phenyl substituiert sind, wobei der Phenylrest seinerseits mit Halogen, N0 2 ,CN oder C 1 -C 4 -Alkoxy substituiert sein kann, oder R 4 Aryl oder Heteroaryl bedeutet, wobei die Aryl- oder Heteroarylreste gegebenenfalls mit C 1 -C 4 -Alkyl, C 1 -C 4 -Alkoxy, Halogen, N0 2 , CN oder N-Sgr. substituiert sind, wobei Sgr. eine Aminoschutzgruppe darstellt, oder in der R 3 und R 4 zusammen einen Alkenylen-Rest der Formeln Illa,b darstellen, in der n 1, 2 oder 3 ist und R 5 und R 6 gleich oder verschieden sind und Wasserstoff, C 2 -C 4 -Alkenyl, C 1 -C 4 -Alkyl oder R 5 und R 6 zusammen anelliertes Phenyl oder anelliertes Naphthyl bedeuten, wobei der Phenyl-oder Naphthyl-Rest gegebenenfalls C 1 -C 4 -Alkyl-, C 1 -C 4 -Alkoxy-, N0 2 -, CN- oder halogensubstituiert ist, wobei der Alkenylen-Rest der Formel III auch noch eine Ketogruppe aufweisen kann und anschließend den entstandenen optisch reinen Alkohol der Formel II isoliert und gegebenenfallsdas andere Enantiomere aus dem verbliebenen Ester gewinnt.
- 2Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß mindestens eine der nachfolgenden Bedingungen erfüllt ist:R 1 bedeutet C 1 -C 4 -Alkyl, welches gegebenenfalls chlorsubstituiert ist;R 3 bedeutet C 1 -C 7 -Alkyl, welches gegebenenfalls chlorsubstituiert ist, oder R 3 bedeutet C 3 -C 5 -Cycloalkyl;R 4 bedeutet C 1 -C 4 -Alkyl, C 2 -C 4 -Alkenyl oder C 2 -C 4 -Alkinyl, wobei die Alkyl-, Alkenyl-oder Alkinylreste gegebenenfalls phenylsubstituiert sind oder R 4 bedeutet Phenyl, Naphthyl, Phenanthryl, Furyl, Thienyl, Pyrrolyl oder Pyridyl, wobei diese Reste gegebenenfalls ihrerseits mit Halogen, N0 2 , CN, C 1 -C 4 -Alkyl oder C, -C 4 -Alkoxy substituiert sind, R 5 und R 6 bilden zusammen anelliertes Phenyl.
- 3Verfahren nach Anspruch 1 oder 2, dadurch gekennzeichnet, daß mindestens eine der nachfolgenden Bedingungen erfüllt ist:R 1 bedeutet Methyl oder Chlormethyl R 3 bedeutet C 1 -C 5 -Alkyl, welches gegebenenfalls chlorsubstituiert ist oder R 3 bedeutet Cyclopropyl R 4 bedeutet Phenyl, Naphthyl, Phenanthryl, Furyl oder Pyridyl, wobei diese Reste gegebenenfalls ihrerseits mit N0 2 oder Methoxy substituiert sind.
- 4Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß als racemischer Alkohol der Formel II eine der in Tabelle 1 aufgeführten Verbindungen eingesetzt wird.
- 5Verfahren nach einem oder mehreren der Ansprüche 1 bis 4, dadurch gekennzeichnet, daß Lipase von Pseudomonas eingesetzt wird.
Independent claims5
26 paragraphs, as filed
0001The invention relates to a process for the enzymatic resolution of racemic alcohols with or in vinyl esters by transesterification, wherein the vinyl ester is split into a ketone or an aldehyde and an "acid residue" and the remaining acid residue forms an ester enantioselectively with an added racemic alcohol and only one enantiomer of the alcohol remains unchanged. Esters and unreacted alcohol and thus both enantiomeric alcohols can be easily separated from one another. The second enantiomer of the alcohol can optionally be obtained by cleaving the ester.
0002Many optically active alcohols are important chiral precursors of biologically active substances (pharmaceuticals, natural substances, plant protection products) and an economical manufacturing process is therefore of great importance. Some pharmacological active ingredients, the presentation of which is facilitated by the process according to the invention, are, for example, NSAIDs (non-steroidal anti-inflammatory drugs) such as ibuprofen and naproxen, beta blockers such as nifenalol and penbutolol, bronchospasmolytics such as tolubuterol and bitolterol, antimycotics such as tioconazole, pyrethroids and pyrethroids such as in addition tetramisole, tetrahydrozoline, (R) - (-) - tomoxetine and (S) - (+) - fluoxetine as well as prostaglandins and carbohydrates.
0003It is known that vinyl esters can be transesterified with the addition of alcohols in the presence of solvents such as tetrahydrofuran under enzymatic catalysis (Degueil-Castaing et al., M. Tetrahedron Letters, Vol. 28, No. 9, pages 953-954, 1987). PPL (Pig Pancreatic Lipase) was used as the enzyme. Stereoselectivity was not observed in the reaction.
0004Atushi Makita et al. describe in Tetrahedron Letters, Vol. 28, No. 7, pages 805-808, 1987 the use of Lipase P for the "lactonization" of w-hydroxycarboxylic acid methyl esters in organic solvents such as cyclohexane, chloroform, hexane, heptane, benzene, toluene or dimethyl sulfoxide.
0005In German patent application P 36 24 703.0, it was proposed to present chiral compounds optically pure from prochiral diols by reaction with vinyl acetate in the presence of hydrolases. This is achieved by selective esterification of only one of the two enantiotopic primary OH groups.
0006It has now surprisingly been found that racemic alcohols can be separated enzymatically by subjecting them to a selective enzyme-catalyzed transesterification reaction with vinyl esters, it being possible to dispense with solvents. Lipases from pig liver and pig pancreas and from microorganisms such as Candida, Mucor, Rhizopus, Penicillium and in particular from Pseudomonas spec. Such as Lipase P and Lipase FP (Amano, Japan) can be used as enzymes.
0007This was all the more surprising since it was previously assumed that the carbonyl compounds (aldehydes or ketones) released react with the lipases and deactivate them.
0008The invention thus relates to:<ul id="ul0001" list-style="none"><li>A process for the enzymatic resolution of racemic alcohols, using a vinyl ester of the formula I,<chemistry id="chem0001" num="0001"><img file="EP0321918B1_D0001.tif" /></chemistry>in the<ul id="ul0002" list-style="none"><li>R<sup>1</sup> Hydrogen, C<sub>1</sub>-C<sub>18</sub>-Alkyl, which is optionally substituted with halogen, phenyl or (C1-C<sub>3</sub>) Alkoxy- (G -C<sub>4 </sub>) Alkyl and</li><li>R<sup>2</sup> Means hydrogen or methyl,</li><li>in the presence of lipases from pig liver, pig pancreas and from microorganisms such as Candida, Mucor, Rhizopus, Penicillium, Aspergillus and Pseudomonas reacted with an alcohol</li><li>Formula 11,<chemistry id="chem0002" num="0002"><img file="EP0321918B1_D0002.tif" /></chemistry>in the</li><li>R<sup>3</sup> C.<sub>1</sub>-C<sub>18</sub>-Alkyl or C3-Clo-Cycloalkyl means, where these radicals can also be halogen-substituted, and</li><li>R<sup>4</sup> Epoxi-C<sub>1</sub>-C<sub>5</sub>-Alkyl means that the epoxy group is in the β-position to the OH group in the rest of the formula II or</li><li>R<sup>4</sup> C.<sub>1</sub>-C<sub>10</sub>-Alkyl, C<sub>1</sub>-C<sub>10</sub>Alkenyl, C<sub>2</sub>-C<sub>10</sub>Alkynyl, C<sub>3</sub>-C<sub>8</sub>-Cycloalkenyl, the alkyl, alkenyl, alkynyl and cycloalkenyl radicals optionally with COOH, halogen, N0<sub>2</sub>, CN, C<sub>1</sub>-C<sub>4</sub>-Alkoxycarbonyl or phenyl are substituted, the phenyl radical in turn with halogen, N0<sub>2</sub> , CN or C<sub>1</sub>-C<sub>4</sub>-Alkoxy may be substituted, or R<sup>4</sup> Aryl or heteroaryl means, the aryl or heteroaryl radicals optionally with C1-C<sub>4</sub>-Alkyl, C1-C<sub>4</sub>-Alkoxy, halogen, N0<sub>2</sub>, CN or N Sgr. are substituted, with Sgr. represents an amino protecting group, or in the</li><li>R<sup>3</sup> and R<sup>4</sup> together an alkylene or alkenylene radical of the formula Illa, b<chemistry id="chem0003" num="0003"><img file="EP0321918B1_D0003.tif" /></chemistry>represent in the</li><li>n is 1, 2 or 3 and</li><li>R<sup>5</sup> and R<sup>6</sup> are the same or different and are hydrogen, C<sub>2</sub>-C<sub>4</sub>-Alkenyl, C1-C4-alkyl or</li><li>R<sup>5</sup> and R<sup>6</sup> together fused phenyl or fused naphthyl, the phenyl or naphthyl radical optionally being C<sub>1</sub>-C<sub>4</sub>-Alkyl-, C<sub>1</sub>-C<sub>4</sub>-Alkoxy-, N0<sub>2</sub>-, CN- or halogen-substituted, where a methylene unit of the alkenylene chain can also be replaced by a carbonyl group, and then isolated the resulting optically pure alcohol of formula II and optionally the other enantiomer from the remaining ester.</li></ul></li></ul>
0009Halogens are understood to mean fluorine, chlorine, bromine and iodine, in particular chlorine and bromine. “Aryl” means, for example, phenyl, naphthyl, phenanthryl, anthryl and fluorenyl, in particular phenyl, naphthyl and phenanthryl. "Heteroaryl" means, for example, furyl, thienyl, pyrrolyl, pyridyl, pyrimidyl, pyrazinyl, imidazolyl, oxazolyl, thiazolyl and indolyl, in particular furyl, thienyl, pyrrolyl and pyridyl. Under the amino protection group "Sgr." are understood the amino protecting groups usually used in peptide chemistry, for example benzyloxycarbonyl (Cbz = Z), benzoyl, benzyl, butyloxycarbonyl (Boc), 9-fluorenyl-methoxycarbonyl (Fmoc), benzhydryl, allyloxycarbonyl (Aloc), tosyl, methoxymethyl (MOM), Tetrahydropyrany (THP), acetyl, but also alkyl or cycloalkyl groups, such as N-methyl, N, N-dimethyl, or piperidine or morpholine. Under "fused phenyl" or "fused naphthyl" is understood to mean a phenyl or naphthyl radical in which the CC double bond of the radical of the formula III is part of the phenyl or naphthyl radical. The optionally substituted radicals R<sup>1</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup> and R<sup>6</sup> are preferably monosubstituted.
0010Alkyl and alkenyl radicals with 3 and more carbon atoms and alkynyl radicals with 4 and more carbon atoms can be either straight-chain or branched. Particular preference is given to using one of the compounds listed in Table 1 as the racemic alcohol of the formula II.
0011The process according to the invention has the following advantages over conventional processes for resolving alcohols:<ul id="ul0003" list-style="none"><li>a) At least one enantiomer is always (optically) highly pure, usually even both;</li><li>b) The enzyme used can be easily recovered;</li><li>c) The separation of the "ester" formed during the cleavage from the "alcohol" is very simple, ideally the two can be separated by distillation;</li><li>d) dispensing with an additional solvent;</li><li>e) High and fast turnover when using comparatively low amounts of enzyme.</li></ul>
0012In the process according to the invention, the vinyl ester of the formula I is split into carboxylic acid and the corresponding vinyl alcohol. The vinyl alcohol immediately rearranged into a ketone or an aldehyde. A reverse reaction is therefore completely prevented. Under the catalytic action of the lipases mentioned, one enantiomer from the racemic alcohol is selectively esterified quickly and in high yields, the other enantiomer remains unchanged in the reaction mixture.
0013The process according to the invention is particularly suitable for cleaving alcohols which have a CC double or triple bond in the β position to the OH group, or which have an epoxide or a double bond equivalent such as a C in this position<sub>3</sub>- own ring.
0014The process according to the invention is best carried out by introducing the vinyl ester of the formula I, preferably vinyl acetate or vinyl chloroacetate, and adding both the enzyme and the alcohol to be split to this solution. A lipoprotein lipase from Pseudomonas spec., In particular Lipase P or Lipase FP, which are commercially available (Amano Pharmaceuticals, Nagoya, Japan), is preferably used as the enzyme. In addition, the enzyme can also be used in immobilized form, with all common immobilization methods and carriers being suitable for this. Immobilized enzyme and free enzyme can also be used in the column process. The amount of enzyme is chosen depending on the size of the batch, the reactivity of the alcohol, the desired reaction time and the type of enzyme (free or fixed) and can easily be determined in individual cases by simple preliminary tests. The alcohol to be split is used in concentrations of 1% to 200%, preferably from 10% to 40%, based on the volume of the vinyl or methyl vinyl ester used. In some cases it is even possible to present vinyl esters only in stoichiometric amounts, based on an enantiomer.
0015The reaction temperature is -10<sub>°</sub>C to 100<sub>°</sub>C, preferably 15<sub>°</sub>C to 50 ° C. It is advisable to stir the solution during the reaction. The reaction times vary depending on the racemic alcohol used and depending on the amount of enzyme between a few hours and up to 4 weeks; however, the majority of cases are between 3 hours and 3 days.
0016Unless commercially available, the vinyl or methyl vinyl esters of the formula I can be prepared in a simple manner, for example by transesterification of vinyl acetate with the corresponding carboxylic acids.
0017The racemic alcohols of the formula 11 are obtained if they are not commercially available, for example by reduction from the corresponding ketones, which are usually commercially available, or by a-bromination of corresponding ketones with subsequent reduction to alcohol. Other non-commercially available alcohols or ketones can be easily prepared using processes known from the literature, for example using Grignard or other common addition reactions.
0018The products formed in the process according to the invention, acetaldehyde or acetone, carboxylic acid ester and alcohol, can be separated in a known manner. Ideally, the unreacted alcohol is obtained by separation by distillation. If separation by distillation is not possible, the separation is carried out chromatographically or by extraction or crystallization. One way of increasing the boiling point difference between the enzymatically formed lower ester and the unreacted alcohol is to use the corresponding vinyl a-halo-carboxylic acid ester instead of vinyl ester (e.g. vinyl a-chloroacetic acid ester).
0019If the other enantiomer is also to be shown in pure form, the ester is first isolated and this is split into acid and alcohol in a known manner.
0020This gives alcohols with enantiomeric purities of over 95% (ee value).
0021The enzyme used for the reactions can easily be recovered by filtration.
0022The invention is explained in detail in the following examples.
example
General working instructions
0023The racemic alcohol is dissolved or suspended in vinyl ester. Lipase P (or Lipase FP) is added in free or fixed form and the mixture is stirred at the temperature given in Table 1. When the reaction has ended, the enzyme is filtered off (both the free and the fixed enzyme can be reused), the remaining solution is evaporated to dryness in vacuo and the alcohol / ester mixture which remains as a residue is separated by column chromatography on silica gel or by extraction, crystallization or distillation.
0024Table 1 shows the products obtained, the variable process parameters (amount of enzyme, amount of alcohol, amounts of vinyl ester, reaction temperature, reaction time) as well as product characteristics and chemical yield.<tables id="tabl0001" num="0001"><img file="EP0321918B1_D0004.tif" /></tables><tables id="tabl0002" num="0002"><img file="EP0321918B1_D0005.tif" /></tables><tables id="tabl0003" num="0003"><img file="EP0321918B1_D0006.tif" /></tables><tables id="tabl0004" num="0004"><img file="EP0321918B1_D0007.tif" /></tables><tables id="tabl0005" num="0005"><img file="EP0321918B1_D0008.tif" /></tables>
17 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US11034710B2 | Cited by | United States of America | Applicant |
| US10624880B2 | Cited by | United States of America | Applicant |
| US11530231B2 | Cited by | United States of America | Applicant |
| US12338261B2 | Cited by | United States of America | Applicant |
| US12077554B2 | Cited by | United States of America | Applicant |
| US10568887B2 | Cited by | United States of America | Applicant |
| US11497756B2 | Cited by | United States of America | Applicant |
| US11279694B2 | Cited by | United States of America | Applicant |
| US10562925B2 | Cited by | United States of America | Applicant |
| US10835537B2 | Cited by | United States of America | Applicant |
| US10682356B2 | Cited by | United States of America | Applicant |
| EP0191217A | Cites | European Patent Office (EPO) | – |
| EP0266217A | Cites | European Patent Office (EPO) | – |
| TETRAHEDRON LETTERS, Band 28, Nr. 9, 1987, Seiten 953-954, Pergamon JournalsLtd, GB; M. DEGUEIL-CASTAING et al.: "Enzymatic reactions in organic synthess: | Non-patent | – | – |
| 2- ester interchange of vinyl esters" | Non-patent | – | – |
| J. AM. CHEM. SOC., Band 110, 1988, Seiten 7200-7205, American Chemical Society;Y.-F. WANG et al.: "Lipase-catalyzed irreversible transesterifications usingenol esters as acylating reagents: preparative enantio- and regioselectivesyntheses of alcohols, glycerol derivatives, sugars, and organometallics" | Non-patent | – | – |
| J. BIOCHEM., Band 104, Nr. 5, 1988, Seiten 681-682; T. NISHIO et al.:"Enzymatic transesterification with the lipase from Pseudomonas fragi 22.39 Bin a non-aqueous reaction system" | Non-patent | – | – |
4 priority claims, no other members on record
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 3743824 | Germany | – | |
| 3743824 | Germany | A | |
| DE19873743824 | – | – | – |
| 3743824 | – | – | – |
51 legal events, as 4 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Be: patent expiredExpiredBE20 | BE20 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Change of name or company nameCD | CD | FR | |
| Name/firm changedPFA | PFA | CH | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Nl: receipt of modified translations in the netherlands language after an opposition procedureOppositionNLR3 | NLR3 | EP | |
| AssignmentPUE | PUE | CH | |
| Fr: translation filed ** decision concerning oppositionOppositionET3 | ET3 | EP | |
| Gb: translation of amended ep patent filed (gb section 77(6)(b)/1977)GBTA | GBTA | EP | |
| Nl: decision of oppositionOppositionNLR2 | NLR2 | EP | |
| Scope or validity of the patent modifiedAUFRECHTERHALTUNG DES PATENTES IN GEAENDERTER FORMAEN | AEN | CH | |
| Patent maintained in amended form27A | 27A | EP | |
| Designated contracting statesAK | AK | EP | |
| Information on inventor provided after grant (corrected)KELLER, REINHOLD, DR. * HOLLA, WOLFGANG, DR. * FUELLING, GERD, DR. * PROF. DR. MANFRED SCHNEIDERRIN2 | RIN2 | EP | |
| Patent maintained in amended formORIGINAL CODE: 0009272PUAH | PUAH | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT MAINTAINED AS AMENDEDSTAA | STAA | EP | |
| Interlocutory decision in oppositionOppositionORIGINAL CODE: EPIDOS IDOPPLAW | PLAW | EP | |
| Nl: modifications (of names), taken from the european patent patent bulletinNLT2 | NLT2 | EP | |
| Interlocutory decision in oppositionOppositionORIGINAL CODE: EPIDOS IDOPPLAW | PLAW | EP | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Nl: opposition has been filed with the epoOppositionNLR1 | NLR1 | EP | |
| Opposition filedOpposition26 | 26 | EP | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Gb: translation of ep patent filed (gb section 77(6)(a)/1977)GBT | GBT | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0321918
- Publication, DOCDB
- 0321918
- Publication, EPODOC
- EP0321918
- Application
- 881212740
- Application, DOCDB
- 88121274
- Application, EPODOC
- EP19880121274
Titles5
- German
- Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen mit/in vinylestern durch Umesterung
- English
- Process for the enzymatic racemate cleavage of racemic alcohols with/in vinyl esters by transesterification
- French
- Procédé enzymatique de dédoublement de racémates d'alcools racémiques avec ou dans des esters vinyliques par transestérification.
- German
- Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen mit/in vinylestern durch Umesterung.
- English
- Process for the enzymatic racemate cleavage of racemic alcohols with/in vinyl esters by transesterification.
Classification
- CPC, 2
- C12P7/62
- C12P41/004
- IPC, 3
- A61K31 045
- C12P7 62
- C12P41 00
Designated states8
- Contracting states, 8
- Belgium
- Switzerland
- Germany
- France
- United Kingdom
- Italy
- Liechtenstein
- Netherlands (Kingdom of the)
